@JCoselli_MD giving the Core Curriculum lecture this morning for ⁦@BCM_CTSurgery⁩ residents. Great historical lecture! 🫀 TAAA requires careful preop mapping & planning 🫀 Multidisciplinary teams

Residency interview season is upon us! Interested medical students, please join us for a virtual open house for the BCM Integrated Cardiothoracic Surgery (i6) training program on October 16th at 7PM CST! Find meeting info here: tinyurl.com/bcmcti6

What an incredible feeling on the last day after training with giants in #aortic and #cardiacsurgery, finishing the last 2 cases of the day while having cake in between, giving a last good hug to other fellows, passing on the baton, feeling so grateful for this unbelievable opportunity. Thank you @THI_Research @BCM_CTSurgery 🙏

Love being at a place that celebrates innovation everyday. Outcomes from the most recent total artificial heart clinical study @BCM_Surgery @BCM_CTSurgery #BCMresearchday2025

Our very own Chief i6 CT surgery resident @NayaMohanMD presenting her research on compounding aortic repairs today at the Michael E. Debakey Research Day. Terrific work! #SurgeryResearchDay @bcmhouston @BCM_Surgery

World’s expert Dr. Taylor Ripley is teaching our CT Surgery residents ⁦⁦@BCM_CTSurgery⁩ everything they need to know about #mesothelioma. He dedicates his life to leading #science incorporating #immunotherapy conducting #mesotheliomaResearch is an ⁦@NIH⁩ -funded

Exciting news! In February 2025, Dr. Joseph Coselli received the prestigious Lifetime Achievement Award at the Transformative Endovascular Decisions (TED) Conference, recognizing his decades of innovation and leadership in aortic surgery.

Congratulations to Dr. R. Taylor Ripley! One year ago, Dr. @RTaylorRipley performed his first slipping rib syndrome repair—and since then, he has helped countless patients find relief from this often painful and overlooked condition. His dedication to innovation and patient-centered care continues to set a new standard in thoracic surgery. Here’s to one year of making a difference and many more ahead! #thoracic #surgeon @bcmhouston

Slipping Rib Syndrome is an often-overlooked cause of lower chest and upper abdominal pain, stemming from hypermobility of costal cartilage and subsequent intercostal nerve irritation. @RTaylorRipley, a thoracic surgeon at Baylor College of Medicine, is one of the few surgeons in the United States performing surgical costal margin reconstruction surgery. This technique involves cartilage resection, autotransplantation and bioresorbable plating to stabilize the rib cage and prevent recurrent nerve impingement. Dr. Ripley is at the forefront of surgical innovation, offering a promising solution for individuals experiencing chronic chest wall pain and reduced mobility. Medical illustrations created by Scott Holmes, CMI #SlippingRibSyndrome #ThoracicSurgery #BaylorMedicine

Finishing out the final Chief Talks Grand Rounds with the graduating chief photos 📸 the sadness of y’all leaving may or may not be setting in already, we love you all! #BaylorMade @BCM_Surgery @BCM_SurgeryOPD @BCMGlobalSurg @ronaldcottonmd

Congrats! We’re thrilled you’ll be joining us and look forward to working together. As Dr Sugarbaker would say, “Expect great things.”

Congratulations to our PGY2 integrated resident @ryannowrouzi on his oral presentation on anastomotic pseudoaneurysms at @AATS. A rising ⭐️! @AATSHQ @JCoselli_MD @green_mph @SXC71 @MarcMoonMD #AATS2025

A 20-year review @VAHouston aterial graft choice. Great job Alex and team #aortaEd

⁦@JCoselli_MD⁩ Discussing Valve Sparing procedures in Patients with Marfan Syndrome at the AATS Plenary. ⁦@BCM_Surgery⁩ ⁦@Texas_Heart⁩ ⁦@AATSHQ⁩ ⁦@BCM_CTSurgery⁩ ⁦@MarfanFdn⁩

Dr. Alexander Schutz presenting in the plenary session on arterial grafting and CABG. ⁦@BCM_Surgery⁩ ⁦@Texas_Heart⁩ ⁦@AATSHQ⁩ ⁦@BCM_CTSurgery⁩

Stephanie Chang presenting her experience doing the world’s first #robotic lung #transplant ⁦@AATSHQ⁩ #AATS2025 Incredible!

#AATS2025 @AATSHQ Dan Jones & N Altorki looking at the effect of SBRT-IO vs chemo-IO in a retrospective trial Conclusions: Neoadjuvant Chemo-10 and SBRT-IO were associated with similar incidence of: • Major and complete pathologic response • Nodal downstaging • Surgical adverse events • Overall survival Recurrence-free survival was significantly improved with SBRT-IO These results should be interpreted with caution given differences in clinical stage, small numbers, retrospective nature & PD-L1 expression. In the words of J Donnington- “going in and beating up the tumor to expose the antigens and generate a more robust immune response likely plays a role.”